American Medicine Safety and Security Act
- Bill Number
- S. 2986
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-10-08: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Last Updated
- 2025-12-08T16:09:27Z
AI-Generated Summary
Purpose
The American Medicine Safety and Security Act aims to protect the safety and security of drugs and medical devices regulated by the Food and Drug Administration (FDA) by imposing restrictions on who can work at the FDA and how they can access sensitive information. It targets potential risks from ties to specific foreign countries through employment rules, family reporting requirements, and post-employment limitations.
Key Provisions
- Ban on Nationals from Certain Countries: Individuals who are citizens of "foreign countries of concern" (defined as the People's Republic of China, Russia, or Iran) cannot be hired for paid employment or other compensated work at the FDA.
- Family Reporting Requirement: FDA employees or paid workers must report if any immediate family member (mother, father, sibling, or child) is a national of a foreign country of concern. The FDA Commissioner must create a reporting process, and failure to report results in immediate termination of employment or contract.
- Post-Employment Restrictions: For 10 years after leaving the FDA, former employees cannot work (paid or volunteer) for any entity based in a foreign country of concern.
- Existing FDA employees (hired before the law's enactment) must agree to this as a condition of keeping their job.
- New hires (after enactment) must agree as a condition of employment.
- Limits on Data Access: FDA employees or contractors involved in reviewing drug or device approvals cannot access information from other FDA departments, divisions, or offices if:
- They have an immediate family member who is a national of a foreign country of concern, or
- They previously worked (paid or volunteer) for an entity based in such a country.
- Definitions:
- "Foreign country of concern" specifically includes China, Russia, and Iran.
- "Immediate family" is limited to parents, siblings, and children.
Significant Changes to Existing Law
This bill introduces entirely new federal restrictions on FDA hiring, employee disclosures, post-employment activities, and internal data access, which do not currently exist in U.S. law. Previously, FDA employment followed general federal hiring rules without these specific nationality-based bans or family-related reporting mandates. It amends no existing statutes directly but adds these conditions as standalone requirements enforced by the Department of Health and Human Services.
Potential Impacts
- On Government Agencies: The FDA may face challenges in recruiting and retaining a diverse workforce, potentially leading to staffing shortages in drug and device regulation. Enforcement could require new administrative processes, increasing operational costs for the agency.
- On Citizens: U.S. citizens or residents with family ties to China, Russia, or Iran may encounter barriers to FDA employment or face job loss for non-compliance, affecting career opportunities in public health. It could also limit information sharing within the FDA, potentially slowing drug and device approvals.
- On International Relations: The law may heighten tensions with China, Russia, and Iran by signaling distrust, possibly prompting reciprocal restrictions on U.S. professionals or complicating diplomatic efforts in global health cooperation, such as vaccine or medical supply chains.
Main Stakeholders Affected
- FDA Employees and Contractors: Current and prospective workers, especially those with personal or family connections to the specified countries, who must comply with reporting, access limits, and future employment bans.
- Immediate Family Members: Individuals who are nationals of China, Russia, or Iran, as their status indirectly affects relatives' FDA jobs.
- FDA and Department of Health and Human Services: Responsible for implementing and enforcing the rules, including termination processes and data access controls.
- Entities in Foreign Countries of Concern: Companies or organizations based in China, Russia, or Iran that may lose access to former FDA talent for 10 years.
- U.S. Public Health Sector: Indirectly affected through potential delays in FDA operations, impacting drug and device availability for patients and healthcare providers.
Notable Legal, Constitutional, or Political Implications
- Legal Implications: The nationality-based hiring ban and family reporting could invite lawsuits alleging discrimination under civil rights laws (e.g., equal employment opportunity rules), as they differentiate based on national origin. Courts may scrutinize whether these measures are narrowly tailored to national security needs.
- Constitutional Implications: Potential challenges under the Equal Protection Clause of the 14th Amendment or the right to free association (1st Amendment), as the law restricts employment based on family ties or past work history without individualized suspicion of wrongdoing. It may also raise due process concerns for terminations without hearings.
- Political Implications: The bill emphasizes national security in healthcare regulation, aligning with broader U.S. policies on foreign influence (e.g., in technology or espionage). However, it could spark debates over balancing security with workforce diversity and civil liberties, influencing future legislation on federal employment in sensitive sectors.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Recent Actions
- 2025-10-08: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2025-10-08: Introduced in Senate
Bill Versions
- American Medicine Safety and Security Act — issued 2025-10-08 — PDF (4 pages)